Olema Pharmaceuticals, Inc.·4

Apr 7, 4:30 PM ET

Kovacs Shane William Charles 4

4 · Olema Pharmaceuticals, Inc. · Filed Apr 7, 2023

Insider Transaction Report

Form 4
Period: 2023-04-06
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
  • Purchase

    Common Stock

    2023-04-06+10,000396,197 total
Footnotes (2)
  • [F1]The weighted average purchase price for the transaction reported was $3.4173, and the range of prices were between $3.375 and $3.42. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
  • [F2]Includes 5,000 shares acquired under the issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    form4-04072023_040409.xmlPrimary